United States Últimas notícias

S&P Global (NYSE:SPGI) agreed to acquire OpenZeppelin, a provider of onchain security standards and smart contract technology, in a transaction announced September 17, 2026.

Almonty Industries (NASDAQ:ALM) entered into a long-term tungsten concentrate supply agreement with Wolfram Bergbau und Hütten AG (WBH), a subsidiary of the Sandvik Group, covering tungsten recovery from existing tailings at the Los Santos Mine in western Spain.

"It doesn't feel like a really robust market environment," says Savita Subramanian, head of US equity and quantitative strategy at BofA Securities. She explains why she expects a pullback in equity markets, despite raising her year-end target for the S&P 500 to 7,400.

Sonal Desai, fixed income CIO at Franklin Templeton, discusses what Federal Reserve Chairman Kevin Warsh accomplished as the central bank raised interest rates for the first time in three years. "What I saw was just somebody who seems to be trying to bring us back to what I would consider a good, normal space," she tells "Bloomberg Surveillance."

Bank7 Corp. (NASDAQ:BSVN) agreed to acquire 100% of Century Financial Services Corporation, the parent company of Century Bank, under a definitive merger agreement announced September 17, 2026.

Nuvation Bio (NASDAQ:NUVB) received U.S. Food and Drug Administration approval for a supplemental New Drug Application updating efficacy information for IBTROZI (taletrectinib) in TKI-naïve adults with advanced ROS1-positive non-small cell lung cancer.

Jane Foley, Rabobank Head of FX Strategy, joins Guy Johnson on "Bloomberg Brief" to discuss her reaction to the Federal Reserve raising interest rates and states Chair Warsh "had to win his credibility."

Bristol Myers Squibb (NYSE:BMY) reported positive two-year results from the Phase 3 POETYK PsA-2 study and its open-label extension, showing continued efficacy and a consistent safety profile for Sotyktu (deucravacitinib) in adults with active psoriatic arthritis.

AECOM (NYSE:ACM) announced that its Board of Directors declared a quarterly cash dividend of $0.31 per share as part of its ongoing dividend program.

Indivior Pharmaceuticals (NASDAQ:INDV) declared a contingent special cash dividend of $8.13 per share, with payment dependent on the completion of its pending merger with Supernus Pharmaceuticals.

Centrus Energy (NYSE:LEU) signed a definitive multi-year contract to supply High-Assay Low-Enriched Uranium (HALEU) to Antares Nuclear, with deliveries scheduled to begin before the end of the decade.

President Donald Trump criticized what he said was a "hostile" Federal Reserve board after the central bank unanimously defied his calls to lower borrowing costs, but said he still had confidence in Fed Chairman Kevin Warsh. Tyler Kendall reports on Bloomberg Television.